Anil K. Dudani

1.5k total citations
35 papers, 1.2k citations indexed

About

Anil K. Dudani is a scholar working on Molecular Biology, Hematology and Biotechnology. According to data from OpenAlex, Anil K. Dudani has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Hematology and 8 papers in Biotechnology. Recurrent topics in Anil K. Dudani's work include Protease and Inhibitor Mechanisms (8 papers), Transgenic Plants and Applications (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Anil K. Dudani is often cited by papers focused on Protease and Inhibitor Mechanisms (8 papers), Transgenic Plants and Applications (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Anil K. Dudani collaborates with scholars based in Canada, India and United States. Anil K. Dudani's co-authors include Radhey S. Gupta, Calvin B. Harley, Peter R. Ganz, S. K. Jindal, Balpreet Singh, E. Tackaberry, Bhag Singh, Ravinder Sardana, Satish Jindal and Illimar Altosaar and has published in prestigious journals such as Molecular and Cellular Biology, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Anil K. Dudani

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anil K. Dudani Canada 16 817 239 210 135 134 35 1.2k
Terence Cartwright France 15 552 0.7× 116 0.5× 90 0.4× 126 0.9× 109 0.8× 41 1.1k
Barry J. Lamphear United States 20 1.7k 2.1× 194 0.8× 294 1.4× 30 0.2× 149 1.1× 22 2.4k
Geoffrey Yarranton United States 29 1.7k 2.1× 193 0.8× 83 0.4× 80 0.6× 140 1.0× 53 2.5k
Gordon Tribbick Australia 16 1.0k 1.2× 389 1.6× 78 0.4× 53 0.4× 313 2.3× 30 1.9k
Jean‐François Haeuw France 21 944 1.2× 603 2.5× 78 0.4× 22 0.2× 241 1.8× 35 1.8k
Hidekatsu Iha Japan 20 528 0.6× 546 2.3× 87 0.4× 171 1.3× 92 0.7× 49 1.2k
Lloyd W. Law United States 27 736 0.9× 786 3.3× 103 0.5× 95 0.7× 193 1.4× 84 2.0k
Fred R. Frankel United States 26 979 1.2× 362 1.5× 258 1.2× 34 0.3× 128 1.0× 52 1.8k
Theresa H.T. Coetzer South Africa 22 596 0.7× 202 0.8× 61 0.3× 155 1.1× 433 3.2× 61 1.6k
D. B. Thomas Tanzania 24 881 1.1× 698 2.9× 62 0.3× 37 0.3× 362 2.7× 69 1.9k

Countries citing papers authored by Anil K. Dudani

Since Specialization
Citations

This map shows the geographic impact of Anil K. Dudani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anil K. Dudani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anil K. Dudani more than expected).

Fields of papers citing papers by Anil K. Dudani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anil K. Dudani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anil K. Dudani. The network helps show where Anil K. Dudani may publish in the future.

Co-authorship network of co-authors of Anil K. Dudani

This figure shows the co-authorship network connecting the top 25 collaborators of Anil K. Dudani. A scholar is included among the top collaborators of Anil K. Dudani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anil K. Dudani. Anil K. Dudani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dudani, Anil K., et al.. (2008). Short Communication: Rapid Preparation of Preventive and Therapeutic Whole-Killed Retroviral Vaccines Using the Microbicide Taurine Chloramine. AIDS Research and Human Retroviruses. 24(4). 635–642. 10 indexed citations
2.
Dudani, Anil K., et al.. (2008). Human Fibroblasts Are Permissive for Porcine Cytomegalovirus In Vitro. Transplantation. 86(1). 155–162. 29 indexed citations
3.
Tackaberry, E., Mark R. Schleiss, Peter R. Ganz, et al.. (2008). Sustained Expression of Human Cytomegalovirus Glycoprotein B (UL55) in the Seeds of Homozygous Rice Plants. Molecular Biotechnology. 40(1). 1–12. 9 indexed citations
4.
Dudani, Anil K., et al.. (2007). Plasminogen and angiostatin interact with heat shock proteins. Molecular and Cellular Biochemistry. 300(1-2). 197–205. 6 indexed citations
5.
Sardana, Ravinder, et al.. (2007). Biologically active human GM-CSF produced in the seeds of transgenic rice plants. Transgenic Research. 16(6). 713–721. 31 indexed citations
6.
Dudani, Anil K., et al.. (2005). Angiostatin and plasminogen share binding to endothelial cell surface actin. Biochemistry and Cell Biology. 83(1). 28–35. 19 indexed citations
7.
Tackaberry, E., Margaret Bell, Peter R. Ganz, et al.. (2003). Increased yield of heterologous viral glycoprotein in the seeds of homozygous transgenic tobacco plants cultivated underground. Genome. 46(3). 521–526. 19 indexed citations
8.
Sardana, Ravinder, Anton Andonov, Laurian S. Robert, et al.. (2002). Pharming vaccines for hepatitis and cytomegalovirus: Towards the development of multivalent and subunit vaccines for oral delivery of antigens. Phytochemistry Reviews. 1(1). 55–66. 9 indexed citations
9.
Wright, Kathryn E., Ravinder Sardana, Illimar Altosaar, et al.. (2001). Sorting of Glycoprotein B from Human Cytomegalovirus to Protein Storage Vesicles in Seeds of Transgenic Tobacco. Transgenic Research. 10(2). 177–181. 37 indexed citations
10.
Dudani, Anil K.. (2000). Plasminogen and Tissue Plasminogen Activator Interact with Antithrombin III. Thrombosis Research. 99(6). 635–641. 5 indexed citations
11.
Rubens, Fraser D., Rosalind S. Labow, E. S. Meek, Anil K. Dudani, & Peter R. Ganz. (1997). Tissue Factor Expression by Cells Used for Sodding of Prosthetic Vascular Grafts. Journal of Surgical Research. 72(1). 22–28. 9 indexed citations
12.
Palmer, Douglas S., Anil K. Dudani, Jeanne Drouin, & Peter R. Ganz. (1997). Identification of Novel Factor VIII Inhibitor Epitopes using Synthetic Peptide Arrays. Vox Sanguinis. 72(3). 148–161. 12 indexed citations
13.
Ganz, Peter R., Anil K. Dudani, E. Tackaberry, et al.. (1996). Expression of human blood proteins in transgenic plants: the cytokine GM-CSF as a model protein.. 281–297. 18 indexed citations
14.
Dudani, Anil K., et al.. (1994). Interaction of tissue plasminogen activator with a human endothelial cell 45-kilodalton plasminogen receptor. Biochemistry and Cell Biology. 72(3-4). 126–131. 15 indexed citations
15.
Dudani, Anil K., et al.. (1993). Isolation of a novel 45 kDa plasminogen receptor from human endothelial cells. Thrombosis Research. 69(2). 185–196. 53 indexed citations
16.
Dudani, Anil K., Seyed Ahmad Hashemi, M. T. Aye, & Peter R. Ganz. (1991). Identification of an endothelial cell surface protein that binds plasminogen. Molecular and Cellular Biochemistry. 108(2). 133–9. 19 indexed citations
17.
Ganz, Peter R., et al.. (1991). Characterization of plasminogen binding to human capillary and arterial endothelial cells. Biochemistry and Cell Biology. 69(7). 442–448. 15 indexed citations
18.
Gupta, Radhey S. & Anil K. Dudani. (1989). Mechanism of action of antimitotic drugs: A new hypothesis based on the role of cellular calcium. Medical Hypotheses. 28(1). 57–69. 10 indexed citations
19.
Dudani, Anil K., Radhey S. Gupta, & Vinod K. Gupta. (1988). Species‐specific differences in the toxicity of puromycin towards cultured human and Chinese hamster cells. FEBS Letters. 234(1). 141–144. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terence Cartwright Breakdown of academic impact, for papers by Barry J. Lamphear Breakdown of academic impact, for papers by Geoffrey Yarranton Breakdown of academic impact, for papers by Gordon Tribbick Breakdown of academic impact, for papers by Jean‐François Haeuw Breakdown of academic impact, for papers by Hidekatsu Iha Breakdown of academic impact, for papers by Lloyd W. Law Breakdown of academic impact, for papers by Fred R. Frankel Breakdown of academic impact, for papers by Theresa H.T. Coetzer Breakdown of academic impact, for papers by D. B. Thomas
Rankless by CCL
2026